The following is a listing of some typical prior investments and strategic assignments:
1984-1988
Data Radio Network (ARDIS): Created the first data radio network service company jointly with Motorola. Used Motorola product and established the base for a joint venture withy IBM and resulted in ARDIS.
DTS: Financed, structured and was a Director of a start up company which developed first data on telephone line equipment using ISDN technology. Company sold in 1988.
Cylix: Restructured and turned around the satellite last mile company subsidiary of RCA/GE and sold company to France Telecom.
OTC: Restructured the fiber backbone network company in New York City, which used the subway tunnels for rights of way and sold assets to MFS.
1992-1998
Inzigo: Initial investor in AI software company in Canada.
NPC: Created and initially operated a company which bid for PCS wireless licenses. Raised equity of $60M for bidding. Declined to bid under the FCC rules and turned company into back office management and support for successful bidders. Sold in 1995.
Air Optics: Restructured an Israeli optical communications company which manufactured optical and infra red broadband telecommunications systems. Company successful sold in 1998.
Probity: Restructured and built a medical management software company. Company sold in 1996.
MDSI: Provided investment management support and was Director of MDSI which was brought public in 1994.
2000-Present
http://www.computerworld.com/action/article.do?command=viewArticleBasic&articleId=52433
Linear A Communications: Linear A ( www.linear-a.net )is a WiFi based broadband and telephony company. It has tested the system in Newburyport, MA for several months and has commenced deployment in Keene, NH in April, 2007. Linear A is continuing where Merton had left off except the franchise is no longer required.
Telmarc Gardens: A wholly owned part of Telmarc, Telmarc Gardens is a research and development arm focusing on the development of genetic pathways for understanding flower colors and using this expertise in other areas including cancer genomics and genetic pathways. The work in this area is shown in the publications on this web site. We have learned a great deal about the pathways and are using this knowledge in our investment strategy and management support. http://www.telmarcgardens.com/
Telmarc has been actively developing and investing in medical technology and genomics areas. We believe that these may very well replace many of the more classic technology investments. We have been developing some hands on applications and seeking opportunities.